Prospective Cohort Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair and Ovarian Function Recovery After Induced Abortion

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

Induced abortion is a common method to terminate pregnancy, but during the operation, it is necessary to dilate the cervix and aspirate the uterine cavity. Repeated induced abortions may increase the risk of uterine damage, leading to cervical stenosis or intrauterine adhesions, thinning of the endometrium, which may affect the implantation of fertilized eggs and the development of embryos, and ultimately may lead to infertility or miscarriage. This study aims to explore the effects of combined estrogen and progesterone on endometrial repair and ovarian function recovery after induced abortion.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:

• Age between 18 years old (inclusive) and 40 years old (inclusive)

• Body Mass Index (BMI) ranging from 18.5Kg/㎡ to 23.9Kg/㎡

• Experienced at least 2 abortions or had a missed abortion

• Confirmed gestational age of no more than 10 weeks, and the ultrasonic examination within three days prior to the surgery shows a gestational sac (average of three diameters) of at least 1.0cm, with an embryo length of no more than 3.0cm

• Normal preoperative examination results as per the Clinical Diagnosis and Treatment Guidelines and Technical Operation Standards: Family Planning Volume (2017 Revision)

• Capable of regular follow-ups and willing to sign the informed consent form.

Locations
Other Locations
China
Women's Hospital School Of Medicine Zhejiang University
RECRUITING
Hangzhou
Contact Information
Primary
Xiuxiu Jiang, Ph.D
jiangxiuxiu0418@zju.edu.cn
+8613588709941
Time Frame
Start Date: 2024-05-09
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 200
Treatments
Experimental: Femoston group
Starting from the day of the induced abortion surgery, take 17β-estradiol/dydrogesterone tablets orally for 28 days (take 2mg of 17β-estradiol orally once a day for the first 14 days, and then take 2mg of 17β-estradiol + 10mg of dydrogesterone tablets orally once a day for the next 14 days).The medication product name is called Femoston。
No_intervention: No Femoston group
The blank control group did not receive Femoston(17β-estradiol/dydrogesterone tablets after induced abortion surgery.
Related Therapeutic Areas
Sponsors
Leads: Women's Hospital School Of Medicine Zhejiang University

This content was sourced from clinicaltrials.gov